Leiomyoma simultaneously impair endometrial BMP-2-mediated decidualization and anticoagulant expression through secretion of TGF-β3

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 2, 2011, Pages 412-421

  Sinclair, Donna C ^a   Mastroyannis, Alex ^a   Taylor, Hugh S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; BONE MORPHOGENETIC PROTEIN RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; THROMBOMODULIN; TRANSCRIPTION FACTOR HOXA10; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DECIDUALIZATION; ENDOMETRIAL STROMAL TUMOR; ENDOMETRIUM; ENDOMETRIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MENORRHAGIA; MYOMETRIUM; PRIORITY JOURNAL; PROTEIN SECRETION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERUS MYOMA;

ADULT; ANTITHROMBIN III; BLOOD COAGULATION; BONE MORPHOGENETIC PROTEIN 2; CELLS, CULTURED; DECIDUA; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFERTILITY, FEMALE; LEIOMYOMA; MENORRHAGIA; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; STROMAL CELLS; THROMBOMODULIN; TRANSFORMING GROWTH FACTOR BETA3; UTERINE NEOPLASMS;

EID: 79951686298     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1450     Document Type: Article

References (42)

1. Ezzati M, Norian JM, Segars JH 2009 Management of uterine fibroids in the patient pursuing assisted reproductive technologies. Womens Health (Lond Engl) 5:413-421
2. Brahma PK, Martel KM, Christman GM 2006 Future directions in myoma research. Obstet Gynecol Clin North Am 33:199-224, xiii
3. Buttram Jr VC, Reiter RC 1981 Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 36:433-445 (Pubitemid 11027013)
4. Vercellini P, Zàina B, Yaylayan L, Pisacreta A, De Giorgi O, Crosignani PG 1999 Hysteroscopic myomectomy: long-term effects on menstrual pattern and fertility. Obstet Gynecol 94:341-347 (Pubitemid 29393066)
5. Garcia CR, Tureck RW 1984 Submucosal leiomyomas and infertility. Fertil Steril 42:16-19 (Pubitemid 14086144)
6. Verkauf BS 1992 Myomectomy for fertility enhancement and preservation. Fertil Steril 58:1-15
7. Daftary GS, Taylor HS 2006 Endocrine regulation of HOX genes. Endocr Rev 27:331-355 (Pubitemid 43848302)
8. Taylor HS, Arici A, Olive D, Igarashi P 1998 HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium. J Clin Invest 101:1379-1384 (Pubitemid 28166835)
9. Daftary GS, Taylor HS 2002 Hydrosalpinx fluid diminishes endometrial cell HOXA10 expression. Fertil Steril 78:577-580
10. Cermik D, Selam B, Taylor HS 2003 Regulation of HOXA10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome. J Clin Endocrinol Metab 88:238-243
11. Taylor HS, Bagot C, Kardana A, Olive D, Arici A 1999 HOX gene expression is altered in the endometrium of women with endometriosis. Hum Reprod 14:1328-1331 (Pubitemid 29224916)
12. Rackow BW, Taylor HS 2010 Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivity. Fertil Steril 93:2027-2034
13. Lee KY, Jeong JW, Wang J, Ma L, Martin JF, Tsai SY, Lydon JP, DeMayo FJ 2007 BMP-2 is critical for the murine uterine decidual response. Mol Cell Biol 27:5468-5478 (Pubitemid 47124399)
14. Paria BC, Ma W, Tan J, Raja S, Das SK, Dey SK, Hogan BL 2001 Cellular and molecular responses of the uterus to embryo implantation can be elicited by locally applied growth factors. Proc Natl Acad Sci USA 98:1047-1052 (Pubitemid 32121184)
15. Zhang H, Bradley A 1996 Mice deficient for BMP-2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122:2977-2986 (Pubitemid 26371964)
16. Ying Y, Zhao GQ 2000 Detection of multiple bone morphogenetic protein messenger ribonucleic acids and their signal transducer, Smad 1 during mouse decidualization. Biol Reprod 63:1781-1786
17. Li Q, Kannan A, Wang W, Demayo FJ, Taylor RN, Bagchi MK, Bagchi IC 2007 Bone morphogenetic protein 2 functions via a conserved signaling pathway involving Wnt4 to regulate uterine decidualization in the mouse and the human. J Biol Chem 282:31725-31732 (Pubitemid 350044887)
18. Casslén B, Astedt B 1983 Occurrence of both urokinase and tissue plasminogen activator in human endometrium. Contraception 28: 553-564 (Pubitemid 14126730)
19. Blasi F 1999 Proteolysis, cell adhesion, chemotaxis, and invasiveness are regulated by the uPA-uPAR-PAI-1 system. Thromb Haemost 82:298-304
20. Casslén B, Astedt B 1981 Fibrinolytic activity of human uterine fluid. Acta Obstet Gynecol Scand 60:55-58 (Pubitemid 11191289)
21. Casslen B, Gustavsson B 1991 Expression of cell membrane receptors for urokinase plasminogen activator (u-PA) in the human endometrium increases during the ovarian cycle. Fibrinolysis 5:243-248
22. Schatz F, Lockwood CJ 1993 Progestin regulation of plasminogen activator inhibitor type-1 in primary cultures of endometrial stromal and decidual cells. J Clin Endocrinol Metab 77:621-625 (Pubitemid 23298637)
23. Casslén B, Nordengren J, Gustavsson B, Nilbert M, Lund LR 1995 Progesterone stimulates degradation of urokinase plasminogen activator (u-PA) in endometrial stromal cells by increasing its inhibitor (PAI-1) and surface expression of the u-PA receptor. J Clin Endocrinol Metab 80:2776-2784
24. Cubellis MV, Wun TC, Blasi F 1990 Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J 9:1079-1085
25. Gleeson NC 1994 Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia. Am J Obstet Gynecol 171:178-183 (Pubitemid 24254438)
26. Nordengren J, Casslen B, Lecander I 1996 Plasminogen activator inhibitor 2 in menstrual endometrium and in primary cultures of endometrial cells. Fibrinolysis 10:295-302 (Pubitemid 27019934)
27. Danø K, Behrendt N, Høyer-Hansen G, Johnsen M, Lund LR, Ploug M, Rømer J 2005 Plasminogen activation and cancer. Thromb Haemost 93:676-681 (Pubitemid 40485402)
28. Lwaleed BA, Greenfield R, Stewart A, Birch B, Cooper AJ 2004 Seminal clotting and fibrinolytic balance: a possible physiological role in the male reproductive system. Thromb Haemost 92:752-766 (Pubitemid 39386702)
29. van Hinsbergh VW 2001 The endothelium: vascular control of hemostasis. Eur J Obstet Gynecol Reprod Biol 95:198-201
30. van Zonneveld AJ, Curriden SA, Loskutoff DJ 1988 Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter. Proc Natl Acad Sci USA 85:5525-5529
31. Massagué J 1990 The transforming growth factor-β family. Annu Rev Cell Biol 6:597-641
32. Sozen I, Arici A 2002 Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata. Fertil Steril 78:1-12 (Pubitemid 34722662)
33. Joseph DS, Malik M, Nurudeen S, Catherino WH 2010 Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor β-3. Fertil Steril 93:1500-1508
34. -125I]TGF-β1-binding sites. Endocrinology 135:439-449
35. Arici A, Sozen I, Olive D 1994 Modulation of transforming growth factor-β3 (TGFβ-3) expression in myometrium and leiomyoma. Program of 50th Annual Meeting of American Fertility Society, San Antonio, TX, 1994; pp S31-S32
36. Arici A, Sozen I 2000 Transforming growth factor-β3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil Steril 73:1006-1011
37. Kirkbride KC, Townsend TA, Bruinsma MW, Barnett JV, Blobe GC 2008 Bone morphogenetic proteins signal through the transforming growth factor-β type III receptor. J Biol Chem 283:7628-7637
38. Kim IY, Lee DH, Ahn HJ, Tokunaga H, Song W, Devereaux LM, Jin D, Sampath TK, Morton RA 2000 Expression of bone morphogenetic protein receptors type IA, -IB, and -II correlates with tumor grade in human prostate cancer tissues. Cancer Res 60:2840-2844
39. Kimber SJ 2005 Leukemia inhibitory factor in implantation and uterine biology. Reproduction 130:131-145 (Pubitemid 41149801)
40. Taylor HS, Igarashi P, Olive DL, Arici A 1999 Sex steroids mediate HOXA 11 expression in the human peri-implantation endometrium. J Clin Endocrinol Metab 84:1129-1135 (Pubitemid 29138254)
41. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Köntgen F, Abbondanzo SJ 1992 Blastocyst implantation depends on maternal expression of leukemia inhibitory factor. Nature 359:76-79
42. Charnock-Jones DS, Sharkey AM, Fenwick P, Smith SK 1994 Leukemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time. J Reprod Fertil 101:421-426 (Pubitemid 24233801)